Bone marrow-derived cells are differentially involved in pathological and physiological retinal angiogenesis in mice

Biochemical and Biophysical Research Communications

Volumn 391, Issue 2, 2010, Pages 1268-1273

  Zou, He ^a   Otani, Atsushi ^a   Oishi, Akio ^a   Yodoi, Yuko ^a   Kameda, Takanori ^a   Kojima, Hiroshi ^a   Yoshimura, Nagahisa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone marrow derived stem cell; Pathological angiogenesis; Physiological angiogenesis; Retinal angiogenesis

Indexed keywords

CESIUM 137;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; IRRADIATION; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RADIATION DOSE; RETINA NEOVASCULARIZATION; RETINOPATHY;

ANIMALS; BONE MARROW CELLS; CELL COUNT; CELL MOVEMENT; DISEASE MODELS, ANIMAL; HEMATOPOIETIC STEM CELLS; LEUKOCYTE REDUCTION PROCEDURES; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; RETINA; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

MURINAE; MUS;

EID: 73449112926     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.057     Document Type: Article

References (27)

1. Jonathan S., Tailoi C.L., Jacob P., et al. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 37 (1996) 290-299
2. Harold F.D. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 20 (2002) 94368-94380
3. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8 (2002) 403-409
4. Rajantie I., Ilmonen M., Alminaite A., Ozerdem U., Alitalo K., and Salven P. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104 (2004) 2084-2086
5. Ozerdem U., Alitalo K., Salven P., and Li A. Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3502-3506
6. Espinosa-Heidmann D.G., Reinoso M.A., Pina Y., Csaky K.G., Caicedo A., and Cousins S.W. Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization. Exp. Eye Res. 80 (2005) 369-378
7. Shirakawa K., Furuhata S., Watanabe I., et al. Induction of vasculogenesis in breast cancer models. Br. J. Cancer 87 (2002) 1454-1461
8. T. Asahara, Endothelial progenitor cells for neovascularization, Ernst Schering Res. Found Workshop, 2003, 211-216.
9. Ziegelhoeffer T., Fernandez B., Kostin S., et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. 94 (2004) 230-238
10. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94 (2004) 678-685
11. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin. Oncol. 29 (2002) 10-14
12. Gardiner T.A., Gibson D.S., de Gooyer T.E., de la Cruz V.F., McDonald D.M., and Stitt A.W. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am. J. Pathol. 166 (2005) 637-644
13. Smith L.E., Wesolowski E., McLellan A., et al. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35 (1994) 101-111
14. Otani A., Kinder K., Ewalt K., Otero F.J., Schimmel P., and Friedlander M. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8 (2002) 1004-1010
15. Banin E., Dorrell M.I., Aguilar E., et al. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Invest. Ophthalmol. Vis. Sci. 47 (2006) 2125-2134
16. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
17. Lyden D., Hattori K., Dias S., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7 (2001) 1194-1201
18. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
19. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85 (1999) 221-228
20. Chan-Ling T., Baxter L., Afzal A., et al. Hematopoietic stem cells provide repair functions after laser-induced Bruch's membrane rupture model of choroidal neovascularization. Am. J. Pathol. 168 (2006) 1031-1044
21. Lenk K., Adams V., Lurz P., et al. Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur. Heart J. 26 (2005) 1903-1909
22. Yamamoto K., Kondo T., Suzuki S., et al. Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler. Thromb. Vasc. Biol. 24 (2004) e192-e196
23. Erbs S., Linke A., Adams V., et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ. Res. 97 (2005) 756-762
24. Ritter M.R., Banin E., Moreno S.K., Aguilar E., Dorrell M.I., and Friedlander M. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J. Clin. Invest. 116 (2006) 3266-3276
25. Ishida S., Yamashiro K., Usui T., et al. Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease. Nat. Med. 9 (2003) 781-788
26. Hou H.Y., Wang Y.S., Xu J.F., Wang Y.C., and Liu J.P. The dynamic conduct of bone marrow-derived cells in the choroidal neovascularization microenvironment. Curr. Eye Res. 31 (2006) 1051-1061
27. Yodoi Y., Sasahara M., Kameda T., Yoshimura N., and Otani A. Circulating hematopoietic stem cells in patients with neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 48 (2007) 464-472